A61L 2300/62
Encapsulated active agents
Official title: Encapsulated active agents, e.g. emulsified droplets
A61L2300/62 (Encapsulated active agents) appears on 751 US grants and 1,293 published applications in this corpus.
Search patents in A61L- Granted patents
- 751
- Published applications
- 1,293
- Assignees
- 603
- Inventors
- 2,442
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 4 | 0 |
| 1991 | 3 | 0 |
| 1992 | 4 | 0 |
| 1993 | 6 | 0 |
| 1994 | 15 | 0 |
| 1995 | 8 | 0 |
| 1996 | 12 | 0 |
| 1997 | 10 | 0 |
| 1998 | 14 | 0 |
| 1999 | 13 | 0 |
| 2000 | 9 | 0 |
| 2001 | 8 | 6 |
| 2002 | 13 | 23 |
| 2003 | 13 | 39 |
| 2004 | 12 | 35 |
| 2005 | 8 | 51 |
| 2006 | 9 | 39 |
| 2007 | 14 | 51 |
| 2008 | 7 | 51 |
| 2009 | 7 | 65 |
| 2010 | 18 | 66 |
| 2011 | 20 | 51 |
| 2012 | 39 | 62 |
| 2013 | 37 | 54 |
| 2014 | 48 | 42 |
| 2015 | 35 | 55 |
| 2016 | 24 | 77 |
| 2017 | 37 | 59 |
| 2018 | 46 | 59 |
| 2019 | 38 | 54 |
| 2020 | 38 | 56 |
| 2021 | 33 | 66 |
| 2022 | 32 | 55 |
| 2023 | 28 | 56 |
| 2024 | 38 | 54 |
| 2025 | 26 | 45 |
| 2026 | 18 | 22 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Gum olibanum nanofibers for drug release and wound healing applications8 Sep 2026US 12,728,180 B1King Saud University
- Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications4 Aug 2026US 12,697,419 B2Board of Regents, The University of Texas System
- Microspheres containing therapeutic agents and related methods of use30 Jun 2026US 12,667,544 B2Biosphere Medical, Inc.
- Method for fabrication of additively manufactured, self-gelling structures and their use9 Jun 2026US 12,649,018 B2Dimension Inx Corp
- Implantable capsule2 Jun 2026US 12,642,760 B2Les Hopitaux Universitaires De Geneve
- Fatty acid-grafted hyaluronic acid, dermal filler formulations comprising same, process for preparation and use thereof1 Oct 2026US 2026/0295116 A1MERZ PHARMA GmbH & CO. KGaA
- Use of nanocrystals for drug delivery from a balloon10 Sep 2026US 2026/0263662 A1Boston Scientific Scimed, Inc.
- Magnesium phosphate for treatment of an infection20 Aug 2026US 2026/0241063 A1Bone Solutions, Inc.
- Metal alloys for medical devices30 Jul 2026US 2026/0216408 A1MiRus LLC
- Extracellular vesicles that promote angiogenesis or neovascularisation23 Jul 2026US 2026/0207518 A1The University Court of the University of Edinburgh
Most cited
By later US patents
- Surgical implant and method for controlled release of chemotherapeutic agents1,679US 5,290,271 A1994
- Particle immobilized coatings and uses thereof1,386US 8,679,454 B2SurModics, Inc. · 2014
- Absorbent articles comprising nanoparticles1,110US 7,988,779 B2McNeil-PPC, Inc. · 2011
- Anti-angiogenic compositions and methods of use968US 5,716,981 AAngiogenesis Technologies, Inc. · 1998
- Drug release stent coating process951US 5,837,313 ASchneider (USA) Inc. · 1998